|
|
||||||||
B Regulation by I
B Kinase in Primary Fibroblast-Like Synoviocytes1


*
Division of Rheumatology, Allergy, and Immunology, University of California at San Diego School of Medicine, La Jolla, CA 92093; and
Signal Pharmaceuticals, 5555 Oberlin Drive, San Diego, CA 92121
NF-
B is a key regulator of inflammatory gene transcription and
is activated in the rheumatoid arthritis (RA) synovium. In resting
cells, NF-
B is retained as an inactive cytoplasmic complex by its
inhibitor, I
B. Phosphorylation of I
B targets it for proteolytic
degradation, thereby releasing NF-
B for nuclear translocation.
Recently, two related I
B kinases (IKK-1 and IKK-2) were identified
in immortalized cell lines that regulate NF-
B activation by
initiating I
B degradation. To determine whether IKK regulates
NF-
B in primary cells isolated from a site of human disease, we
characterized IKK in cultured fibroblast-like synoviocytes (FLS)
isolated from synovium of patients with RA or osteoarthritis.
Immunoreactive IKK protein was found to be abundant in both RA and
osteoarthritis FLS by Western blot analysis. Northern blot analysis
showed that IKK-1 and IKK-2 genes were constitutively expressed in all
FLS lines. IKK function in FLS extracts was determined by measuring
phosphorylation of recombinant I
B in vitro. IKK activity in both RA
and osteoarthritis FLS was strongly induced by TNF-
and IL-1 in a
concentration-dependent manner. Activity was significantly increased
within 10 min of stimulation and declined to near basal levels within
80 min. Activation of IKK in FLS was accompanied by phosphorylation and
degradation of endogenous I
B
as determined by Western blot
analysis. Concomitant activation and nuclear translocation of NF-
B
was documented by EMSA and immunohistochemistry. Transfection with a
dominant negative IKK-2 mutant prevented TNF-
-mediated NF-
B
nuclear translocation, whereas a dominant negative IKK-1 mutant had no
effect. This is the first demonstration that IKK-2 is a pivotal
regulator of NF-
B in primary human cells.
This article has been cited by other articles:
![]() |
B. H. Kim, E. Roh, H. Y. Lee, I.-J. Lee, B. Ahn, S.-H. Jung, H. Lee, S.-B. Han, and Y. Kim Benzoxathiole Derivative Blocks Lipopolysaccharide-Induced Nuclear Factor-{kappa}B Activation and Nuclear Factor-{kappa}B-Regulated Gene Transcription through Inactivating Inhibitory {kappa}B Kinase {beta} Mol. Pharmacol., April 1, 2008; 73(4): 1309 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Amos, S. Lauder, A. Evans, M. Feldmann, and J. Bondeson Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor I{kappa}B{alpha} reveals that most, but not all, inflammatory and destructive mediators are NF{kappa}B dependent Rheumatology, October 1, 2006; 45(10): 1201 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Amin, C. S. Haas, K. Zhu, P. J. Mansfield, M. J. Kim, N. P. Lackowski, and A. E. Koch Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NF{kappa}B Blood, March 15, 2006; 107(6): 2252 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cheong, A. Bergmann, S. L. Werner, J. Regal, A. Hoffmann, and A. Levchenko Transient I{kappa}B Kinase Activity Mediates Temporal NF-{kappa}B Dynamics in Response to a Wide Range of Tumor Necrosis Factor-{alpha} Doses J. Biol. Chem., February 3, 2006; 281(5): 2945 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K.W. Au-Yeung, C. W.H. Woo, F. L. Sung, J. C.W. Yip, Y. L. Siow, and K. O Hyperhomocysteinemia Activates Nuclear Factor-{kappa}B in Endothelial Cells via Oxidative Stress Circ. Res., January 9, 2004; 94(1): 28 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nonomura, H. Kohsaka, K. Nagasaka, and N. Miyasaka Gene Transfer of a Cell Cycle Modulator Exerts Anti-Inflammatory Effects in the Treatment of Arthritis J. Immunol., November 1, 2003; 171(9): 4913 - 4919. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Perlman, K. Bradley, H. Liu, S. Cole, E. Shamiyeh, R. C. Smith, K. Walsh, S. Fiore, A. E. Koch, G. S. Firestein, et al. IL-6 and Matrix Metalloproteinase-1 Are Regulated by the Cyclin-Dependent Kinase Inhibitor p21 in Synovial Fibroblasts J. Immunol., January 15, 2003; 170(2): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Cowling, D. Gurantz, J. Peng, W. H. Dillmann, and B. H. Greenberg Transcription Factor NF-kappa B Is Necessary for Up-regulation of Type 1 Angiotensin II Receptor mRNA in Rat Cardiac Fibroblasts Treated with Tumor Necrosis Factor-alpha or Interleukin-1beta J. Biol. Chem., February 15, 2002; 277(8): 5719 - 5724. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Lebovic, V. A. Chao, J.-F. Martini, and R. N. Taylor IL-1{beta} Induction of RANTES (Regulated upon Activation, Normal T Cell Expressed and Secreted) Chemokine Gene Expression in Endometriotic Stromal Cells Depends on a Nuclear Factor-{kappa}B Site in the Proximal Promoter J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4759 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nonomura, H. Kohsaka, K. Nasu, Y. Terada, M.-a. Ikeda, and N. Miyasaka Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21Cip1 gene into the joints Int. Immunol., June 1, 2001; 13(6): 723 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Aupperle, B. L. Bennett, Z. Han, D. L. Boyle, A. M. Manning, and G. S. Firestein NF-{{kappa}}B Regulation by I{{kappa}}B Kinase-2 in Rheumatoid Arthritis Synoviocytes J. Immunol., February 15, 2001; 166(4): 2705 - 2711. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gerlag, L. Ransone, P. P. Tak, Z. Han, M. Palanki, M. S. Barbosa, D. Boyle, A. M. Manning, and G. S. Firestein The Effect of a T Cell-Specific NF-{kappa}B Inhibitor on In Vitro Cytokine Production and Collagen-Induced Arthritis J. Immunol., August 1, 2000; 165(3): 1652 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Perlman, C. Georganas, L. J. Pagliari, A. E. Koch, K. Haines III, and R. M. Pope Bcl-2 Expression in Synovial Fibroblasts Is Essential for Maintaining Mitochondrial Homeostasis and Cell Viability J. Immunol., May 15, 2000; 164(10): 5227 - 5235. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |